Drug intelligence / Profile preview

procyanidin c1

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Procyanidin C1 is a natural polyphenolic compound classified as a B-type proanthocyanidin and a trimer of (-)-epicatechin, commonly found in grape seed, unripe apples, and cinnamon[6][2]. It acts as a senolytic agent, specifically eliminating senescent cells by increasing reactive oxygen species (ROS), promoting mitochondrial dysfunction, causing cytochrome c release, and activating apoptotic pathways including BAX upregulation and caspase activation[1][3]. At low concentrations it inhibits senescence-associated secretory phenotype (SASP), while at higher concentrations it selectively induces apoptosis in senescent cells without affecting normal cells[1][3]. PCC1 demonstrates in vivo activity in rodent models, improving age-related dysfunction and extending lifespan, and has been shown to enhance the efficacy of chemotherapy in tumors with therapy-induced senescence[1][3][6]. It also displays strong antioxidant, anti-inflammatory, and anti-cancer activities[2][5].

Other names
proanthocyanidin c1procyanidol c1procyanidin trimer c1cinnamtannin a1epicatechin trimer
02

Targets

BLM (BLM helicase)

Beyond the preview

Go deeper on procyanidin c1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on procyanidin c1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call